Platinum-Based Cancer Drug Market Set to Reach USD 1.76 Billion by 2032 | Key Growth Insights and Leading Players
According to a new report from Intel Market Research, Global platinum-based cancer drug market was valued at USD 1.44 billion in 2025 and is projected to reach USD 1.76 billion by 2032, exhibiting a CAGR of 2.9% during the forecast …